120 related articles for article (PubMed ID: 38485133)
21. Peritoneal and Nodal Gliomatosis Mimicking Metastasis on FDG PET/CT in a Patient With Ovarian Immature Teratoma.
Lee SM; Choi MC; Lee JW; Kim T; Jang SJ
Clin Nucl Med; 2023 Aug; 48(8):707-709. PubMed ID: 37220221
[TBL] [Abstract][Full Text] [Related]
22.
Cistaro A; Quartuccio N; Piccardo A; Fania P; Spunton M; Liava A; Danesino C; Albani G; Guala A
J Nucl Med; 2020 Aug; 61(8):1195-1199. PubMed ID: 31836684
[TBL] [Abstract][Full Text] [Related]
23. Practice of
van Leer B; van Rijsewijk ND; Nijsten MWN; Slart RHJA; Pillay J; Glaudemans AWJM
Semin Nucl Med; 2023 Nov; 53(6):809-819. PubMed ID: 37258380
[No Abstract] [Full Text] [Related]
24. Role of [(18)F]FDG-PET/CT in the detection of occult recurrent medullary thyroid cancer.
Skoura E; Rondogianni P; Alevizaki M; Tzanela M; Tsagarakis S; Piaditis G; Tolis G; Datseris IE
Nucl Med Commun; 2010 Jun; 31(6):567-75. PubMed ID: 20335822
[TBL] [Abstract][Full Text] [Related]
25. PET/CT studies of multiple myeloma using (18) F-FDG and (18) F-NaF: comparison of distribution patterns and tracers' pharmacokinetics.
Sachpekidis C; Goldschmidt H; Hose D; Pan L; Cheng C; Kopka K; Haberkorn U; Dimitrakopoulou-Strauss A
Eur J Nucl Med Mol Imaging; 2014 Jul; 41(7):1343-53. PubMed ID: 24562650
[TBL] [Abstract][Full Text] [Related]
26. F-18 FDG PET/CT imaging of cardiac and vascular inflammation and infection.
Lawal I; Sathekge M
Br Med Bull; 2016 Dec; 120(1):55-74. PubMed ID: 27613996
[TBL] [Abstract][Full Text] [Related]
27. A rare case of mature teratoma. Has FDG PET/CT a role to play?
Mohapatra T; Arora A; Srikant K; Snehalata ; Kumar N
Indian J Nucl Med; 2011 Apr; 26(2):107-8. PubMed ID: 22174520
[TBL] [Abstract][Full Text] [Related]
28.
Ulaner GA; Castillo R; Wills J; Gönen M; Goldman DA
Eur J Nucl Med Mol Imaging; 2017 Aug; 44(9):1420-1427. PubMed ID: 28456837
[TBL] [Abstract][Full Text] [Related]
29. Assessment of ovarian teratoma and lymphadenopathy by 18F-FDG PET/CT.
Balink H; Apperloo MJ; Collins J
Clin Nucl Med; 2012 Aug; 37(8):804-6. PubMed ID: 22785518
[TBL] [Abstract][Full Text] [Related]
30. The role of integrated (18)F-FDG PET/CT in identification of ectopic ACTH secretion tumors.
Xu H; Zhang M; Zhai G; Zhang M; Ning G; Li B
Endocrine; 2009 Dec; 36(3):385-91. PubMed ID: 19806477
[TBL] [Abstract][Full Text] [Related]
31. Comparison of
Yu HN; Liu L; Chen QS; He Q; Li YS; Wang Y; Gao S
Orthop Surg; 2021 May; 13(3):791-798. PubMed ID: 33709632
[TBL] [Abstract][Full Text] [Related]
32. Comparison of Static and Dynamic
Braune A; Hofheinz F; Bluth T; Kiss T; Wittenstein J; Scharffenberg M; Kotzerke J; Gama de Abreu M
J Nucl Med; 2019 Nov; 60(11):1629-1634. PubMed ID: 31053684
[TBL] [Abstract][Full Text] [Related]
33. The detection of endocarditis, post implantation grafts, arteritis and other related disorders by
Šaponjski J; Šobić-Šaranović D; Odalović S; Stojiljković M; Pantović J; Petrović N; Grozdić-Milojević I; Artiko V
Hell J Nucl Med; 2017; 20 Suppl():37-44. PubMed ID: 29324913
[TBL] [Abstract][Full Text] [Related]
34. Diagnostic Value of
Cengiz A; Göksel S; Yürekli Y
Mol Imaging Radionucl Ther; 2018 Oct; 27(3):126-132. PubMed ID: 30317849
[TBL] [Abstract][Full Text] [Related]
35. Clinical and prognostic value of 18F-FDG-PET/CT in restaging of pancreatic cancer.
Albano D; Familiari D; Gentile R; Scalisi S; Midiri F; Messina M; Spada M; Fornito MC; Galia M; Midiri M; Alongi P
Nucl Med Commun; 2018 Aug; 39(8):741-746. PubMed ID: 29782393
[TBL] [Abstract][Full Text] [Related]
36. A Prospective Study Comparing Functional Imaging (
Prathipati A; Manthri RG; Subramanian BV; Das P; Jilla S; Mani S; J AK; Sarala S; Kottu R; Kalawat TC; Naidu KVJR
Asia Ocean J Nucl Med Biol; 2017; 5(2):75-84. PubMed ID: 28660217
[TBL] [Abstract][Full Text] [Related]
37. Treatment response evaluation with
Sachpekidis C; Hillengass J; Goldschmidt H; Wagner B; Haberkorn U; Kopka K; Dimitrakopoulou-Strauss A
Eur J Nucl Med Mol Imaging; 2017 Jan; 44(1):50-62. PubMed ID: 27573638
[TBL] [Abstract][Full Text] [Related]
38. (18)F-FDG-PET/CT for systemic staging of newly diagnosed triple-negative breast cancer.
Ulaner GA; Castillo R; Goldman DA; Wills J; Riedl CC; Pinker-Domenig K; Jochelson MS; Gönen M
Eur J Nucl Med Mol Imaging; 2016 Oct; 43(11):1937-44. PubMed ID: 27129866
[TBL] [Abstract][Full Text] [Related]
39. (18)F-FDG PET-CT: a powerful tool for the diagnosis and treatment of relapsing polychondritis.
Lei W; Zeng H; Zeng DX; Zhang B; Zhu YH; Jiang JH; Huang JA
Br J Radiol; 2016; 89(1057):20150695. PubMed ID: 26529231
[TBL] [Abstract][Full Text] [Related]
40. Combined use of (18)F-FDG and (18)F-FMISO in unresectable non-small cell lung cancer patients planned for radiotherapy: a dynamic PET/CT study.
Sachpekidis C; Thieke C; Askoxylakis V; Nicolay NH; Huber PE; Thomas M; Dimitrakopoulou G; Debus J; Haberkorn U; Dimitrakopoulou-Strauss A
Am J Nucl Med Mol Imaging; 2015; 5(2):127-42. PubMed ID: 25973334
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
